GRTPA Side Effects

7016841-0 | Haemorrhagic Cerebral Infarction, Hydrocephalus
on Sep 17, 2010 Male patient from JAPAN , 49 years of age, was diagnosed with embolic stroke and was treated with Grtpa (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic cerebral infarction, hydrocephalus (What is hydrocephalus?). Grtpa dosage: 30 Mg, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), D MANNITOL (Unk) (View D-mannitol Review and D-mannitol Label ), GLYCEOL (Unk) (View Glyceol Review and Glyceol Label ), VASODILATOR NOS (View Vasodilator Nos Review and Vasodilator Nos Label ), HEPARIN (Unk) (View Heparin Review and Heparin Label ). Patient was hospitalized.

6956754-3 | Haemothorax
Patient was taking Grtpa (View Usage). Patient had the following side effects: haemothorax on Aug 25, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, was diagnosed with cerebral infarction and. Grtpa dosage: 30.2 Ml, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), HEPARIN SODIUM (3.8 Ml, Unk) (View Heparin Sodium Review and Heparin Sodium Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CILOSTAZOL (Unk) (View Cilostazol Review and Cilostazol Label ), VASODILATORS NOS (240 Mg, Unk) (View Vasodilators Nos Review and Vasodilators Nos Label ), BEPRIDIL HYDROCHLORIDE (150 Mg, Unk) (View Bepridil Hydrochloride Review and Bepridil Hydrochloride Label ).

6922134-X | Haemothorax
Adverse event was reported on Aug 06, 2010 by a Male patient taking Grtpa (View Usage) (Dosage: 30.2 Ml, Unk) was diagnosed with cerebral infarction and. Location: JAPAN , 78 years of age, After Grtpa was administered, patient had the following side effects: haemothorax. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), HEPARIN SODIUM (Unk) (View Heparin Sodium Review and Heparin Sodium Label ), WARFARIN (Unk) (View Warfarin Review and Warfarin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), CILOSTAZOL (Unk) (View Cilostazol Review and Cilostazol Label ), VASODILATORS NOS (View Vasodilators Nos Review and Vasodilators Nos Label ).

6911111-0 | Deep Vein Thrombosis
on Aug 03, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with cerebral infarction and was treated with Grtpa (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Grtpa dosage: 42.9 Mg, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), GLYCEOL (Unk) (View Glyceol Review and Glyceol Label ), HEPARIN SODIUM (Unk) (View Heparin Sodium Review and Heparin Sodium Label ), WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.


6888548-1 | Anaphylactic Shock
on Jul 28, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with cerebral infarction and was treated with Grtpa (View Usage). Patient had the following side effects: anaphylactic shock. Grtpa dosage: 24.9 Ml, Unk. During the same period patient was treated with RADICUT (30 Mg, Unk) (View Radicut Review and Radicut Label ). Patient was hospitalized.

6877063-7 | Deep Vein Thrombosis
Patient was taking Grtpa (View Usage). After Grtpa was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Jul 20, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, was diagnosed with cerebral infarction and. Grtpa dosage: 42.9 Mg, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), GLYCEOL (Unk) (View Glyceol Review and Glyceol Label ), HEPARIN SODIUM (Unk) (View Heparin Sodium Review and Heparin Sodium Label ), WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ). Patient was hospitalized.

6861400-3 | Anaphylactic Shock
Adverse event was reported on Jul 12, 2010 by a Male patient taking Grtpa (View Usage) (Dosage: 24.9 Ml, Unk) was diagnosed with cerebral infarction and. Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with RADICUT (30 Mg, Unk) (View Radicut Review and Radicut Label ). Patient was hospitalized.

6861366-6 | Myocardial Infarction
on Jul 12, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with cerebral infarction and was treated with Grtpa (View Usage). Patient had the following side effects: myocardial infarction. Grtpa dosage: Unk. Patient was hospitalized.

6824335-8 | Cholecystitis Acute
on Jul 01, 2010 Male patient from JAPAN , 55 years of age, was diagnosed with embolic stroke and was treated with Grtpa (View Usage). After Grtpa was administered, patient had the following side effects: cholecystitis acute. Grtpa dosage: 49.3 Ml, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), WARFARIN POTASSIUM (2 Mg, Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), STATIN (UNK INGREDIENTS) (Unk) (View Statin (unk Ingredients) Review and Statin (unk Ingredients) Label ), MEROPEN (JAPAN) (1 G, Unk) (View Meropen (japan) Review and Meropen (japan) Label ). Patient was hospitalized.

6823326-0 | Anaphylactic Shock
Patient was taking Grtpa (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock on Jun 30, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with cerebral infarction and. Grtpa dosage: 2409 Ml, Unk.

6790696-1 | Pulmonary Oedema
Adverse event was reported on Jun 16, 2010 by a Male patient taking Grtpa (View Usage) (Dosage: 35 Ml, Unk) was diagnosed with cerebral infarction and. Location: JAPAN , 57 years of age, Patient had the following side effects: pulmonary oedema. Patient was hospitalized.

6572073-1 | Acute Myocardial Infarction
on Feb 02, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with embolic stroke and was treated with Grtpa (View Usage). After Grtpa was administered, patient had the following side effects: acute myocardial infarction. Grtpa dosage: 31.9 Ml, Unk. During the same period patient was treated with RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), VERAPAMIL HCL (80 Mg, Unk) (View Verapamil Hcl Review and Verapamil Hcl Label ), MICARDIS (40 Mg, Unk) (View Micardis Review and Micardis Label ), WARFARIN POTASSIUM (1.5 Mg, Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ).

6426937-X | Arterial Thrombosis Limb
on Nov 01, 2009 Male patient from JAPAN , 57 years of age, was diagnosed with cerebral infarction and was treated with Grtpa (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis limb. Grtpa dosage: Unk.

6407414-9 | Cardiac Arrest
Patient was taking Grtpa (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Oct 18, 2009 from JAPAN Additional patient health information: Female patient , 77 years of age, weighting 94.80 lb, was diagnosed with embolic stroke and. Grtpa dosage: Unk Mg/kg, Unk. During the same period patient was treated with HEPARIN (Unk) (View Heparin Review and Heparin Label ).

6367552-6 | Cardiac Arrest
Adverse event was reported on Sep 16, 2009 by a Female patient taking Grtpa (View Usage) (Dosage: 0.6 Mg/kg, Unk) was diagnosed with embolic stroke and. Location: JAPAN , 77 years of age, weighting 94.80 lb, After Grtpa was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). During the same period patient was treated with HEPARIN (Unk) (View Heparin Review and Heparin Label ).

5963963-9 | Acute Myocardial Infarction
on Nov 20, 2008 Male patient from JAPAN , 76 years of age, weighting 167.6 lb, was diagnosed with embolic stroke and was treated with Grtpa (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction. Grtpa dosage: 41.4 Mg, Unk. During the same period patient was treated with FAMOTIDINE (40 Mg, Unk) (View Famotidine Review and Famotidine Label ), RADICUT (60 Mg, Unk) (View Radicut Review and Radicut Label ), CATECHOLAMINE NOS (Unk) (View Catecholamine Nos Review and Catecholamine Nos Label ).

5656900-8 | Aortic Dissection, Cardiac Tamponade
on Mar 06, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with carotid artery dissection and was treated with Grtpa (View Usage). Patient had the following side effects: aortic dissection, cardiac tamponade. Grtpa dosage: 0.6 Mg/kg, Unk. During the same period patient was treated with LACTATED RINGER'S (View Lactated Ringer's Review and Lactated Ringer's Label ), DORMICUM (View Dormicum Review and Dormicum Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5620012-X | Aortic Dissection
Patient was taking Grtpa (View Usage). After Grtpa was administered, patient had the following side effects: aortic dissection on Feb 05, 2008 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with cerebral infarction and. Grtpa dosage: .

5586904-5 |
Adverse event was reported on Jan 10, 2008 by a Female patient taking Grtpa (View Usage) (Dosage: Unk, Single) was diagnosed with ischaemic stroke and. Location: GERMANY , 77 years of age, .

5577103-1 | Aortic Dissection
on Dec 26, 2007 Female patient from JAPAN , 72 years of age, was diagnosed with cerebral artery embolism and was treated with Grtpa (View Usage). Patient had the following side effects: aortic dissection. Grtpa dosage: 0.6 Mg/kg, Unk. During the same period patient was treated with LOW MOLECULAR DEXTRAN (500 Ml, Unk) (View Low Molecular Dextran Review and Low Molecular Dextran Label ), GLYCERIN (400 Ml, Unk) (View Glycerin Review and Glycerin Label ), RADICUT (30 Mg, Unk) (View Radicut Review and Radicut Label ).

5569893-9 | Respiratory Failure
on Dec 18, 2007 Male patient from JAPAN , 68 years of age, was diagnosed with cerebral infarction and was treated with Grtpa (View Usage). After Grtpa was administered, patient had the following side effects: respiratory failure. Grtpa dosage: 0.6 Mg/kg, Unk.

5541826-0 |
Patient was taking Grtpa (View Usage). on Dec 04, 2007 from GERMANY Additional patient health information: Female patient , 77 years of age, was diagnosed with ischaemic stroke and. Grtpa dosage: Unk, Single.

5331698-1 | Renal Failure Acute
Adverse event was reported on May 17, 2007 by a Male patient taking Grtpa (View Usage) (Dosage: 41.4 Mg, Unk) was diagnosed with cerebral artery embolism and. Location: JAPAN , 71 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), HERBESSER (View Herbesser Review and Herbesser Label ), LACTEC (View Lactec Review and Lactec Label ), GLYCERIN (View Glycerin Review and Glycerin Label ), FRUCTOSE (View Fructose Review and Fructose Label ), HUMULIN 70/30 (View Humulin 70/30 Review and Humulin 70/30 Label ), LASIX (View Lasix Review and Lasix Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).